表皮生长因子受体抑制剂：现状与未来方向 - Suppr

Suppr

超能文献

Epidermal growth factor receptor inhibitors: current status and future directions.

作者信息

Chen Helen X, Cleck Jessica N, Coelho Rochelle, Dancey Janet E

机构信息

Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, Maryland, USA.

出版信息

Curr Probl Cancer. 2009 Jul-Aug;33(4):245-94. doi: 10.1016/j.currproblcancer.2009.10.002.

DOI:10.1016/j.currproblcancer.2009.10.002

PMID:20082842

Abstract

摘要

相似文献

Epidermal growth factor receptor inhibitors: current status and future directions.

Curr Probl Cancer. 2009 Jul-Aug;33(4):245-94. doi: 10.1016/j.currproblcancer.2009.10.002.

Foreword.

Curr Probl Cancer. 2009 Jul-Aug;33(4):244. doi: 10.1016/j.currproblcancer.2009.10.001.

SRC as a potential therapeutic target in solid tumor oncology.

Clin Adv Hematol Oncol. 2004 Jul;2(7):435-7.

Population differences in the use of EGFR-targeted agents.

Clin Adv Hematol Oncol. 2008 Oct;6(10):730-2.

Novel aspects of epidermal growth factor receptor in relation to tumor development.

FEBS J. 2010 Jan;277(2):300. doi: 10.1111/j.1742-4658.2009.07447.x. Epub 2009 Nov 18.

The HER3/ErbB3 receptor: a promising target in cancer drug therapy.

Gastroenterol Clin Biol. 2010 Apr-May;34(4-5):255-9. doi: 10.1016/j.gcb.2010.03.002. Epub 2010 Apr 24.

Introduction: targeting different pathways to prevent tumor cell development.

Semin Oncol. 2009 Apr;36(2 Suppl 1):S1-5. doi: 10.1053/j.seminoncol.2009.02.003.

Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor.

Oncology (Williston Park). 2003 Jun;17(6):819, 826-30, 833-4 passim.

Clinical biomarkers of kinase activity: examples from EGFR inhibition trials.

Cancer Metastasis Rev. 2008 Sep;27(3):387-402. doi: 10.1007/s10555-008-9141-z.

EGFR targeting therapies: monoclonal antibodies versus tyrosine kinase inhibitors. Similarities and differences.

Crit Rev Oncol Hematol. 2007 Apr;62(1):53-61. doi: 10.1016/j.critrevonc.2006.12.008. Epub 2007 Feb 26.

引用本文的文献

Preclinical antitumor activity of S-222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2.

Cancer Sci. 2014 Aug;105(8):1040-8. doi: 10.1111/cas.12449.

Polyisoprenylated methylated protein methyl esterase overexpression and hyperactivity promotes lung cancer progression.

Am J Cancer Res. 2014 Mar 1;4(2):116-34. eCollection 2014.

Epidermal growth factor receptor (EGFR)-RAS signaling pathway in penile squamous cell carcinoma.

PLoS One. 2013 Apr 24;8(4):e62175. doi: 10.1371/journal.pone.0062175. Print 2013.

Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16.

Virology. 2011 Dec 5;421(1):19-27. doi: 10.1016/j.virol.2011.09.014. Epub 2011 Oct 5.

The Role of EGFR Inhibitors in the Treatment of Metastatic Anal Canal Carcinoma: A Case Series.

J Oncol. 2011;2011:125467. doi: 10.1155/2011/125467. Epub 2011 Jun 13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Epidermal growth factor receptor inhibitors: current status and future directions.

作者信息

Chen Helen X, Cleck Jessica N, Coelho Rochelle, Dancey Janet E

机构信息

Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, Maryland, USA.

出版信息

Curr Probl Cancer. 2009 Jul-Aug;33(4):245-94. doi: 10.1016/j.currproblcancer.2009.10.002.

DOI:10.1016/j.currproblcancer.2009.10.002

PMID:20082842

Abstract

摘要

相似文献

Epidermal growth factor receptor inhibitors: current status and future directions.

Curr Probl Cancer. 2009 Jul-Aug;33(4):245-94. doi: 10.1016/j.currproblcancer.2009.10.002.

Foreword.

Curr Probl Cancer. 2009 Jul-Aug;33(4):244. doi: 10.1016/j.currproblcancer.2009.10.001.

SRC as a potential therapeutic target in solid tumor oncology.

Clin Adv Hematol Oncol. 2004 Jul;2(7):435-7.

Population differences in the use of EGFR-targeted agents.

Clin Adv Hematol Oncol. 2008 Oct;6(10):730-2.

Novel aspects of epidermal growth factor receptor in relation to tumor development.

FEBS J. 2010 Jan;277(2):300. doi: 10.1111/j.1742-4658.2009.07447.x. Epub 2009 Nov 18.

The HER3/ErbB3 receptor: a promising target in cancer drug therapy.

Gastroenterol Clin Biol. 2010 Apr-May;34(4-5):255-9. doi: 10.1016/j.gcb.2010.03.002. Epub 2010 Apr 24.

Introduction: targeting different pathways to prevent tumor cell development.

Semin Oncol. 2009 Apr;36(2 Suppl 1):S1-5. doi: 10.1053/j.seminoncol.2009.02.003.

Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor.

Oncology (Williston Park). 2003 Jun;17(6):819, 826-30, 833-4 passim.

Clinical biomarkers of kinase activity: examples from EGFR inhibition trials.

Cancer Metastasis Rev. 2008 Sep;27(3):387-402. doi: 10.1007/s10555-008-9141-z.

EGFR targeting therapies: monoclonal antibodies versus tyrosine kinase inhibitors. Similarities and differences.

Crit Rev Oncol Hematol. 2007 Apr;62(1):53-61. doi: 10.1016/j.critrevonc.2006.12.008. Epub 2007 Feb 26.

引用本文的文献

Preclinical antitumor activity of S-222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2.

Cancer Sci. 2014 Aug;105(8):1040-8. doi: 10.1111/cas.12449.

Polyisoprenylated methylated protein methyl esterase overexpression and hyperactivity promotes lung cancer progression.

Am J Cancer Res. 2014 Mar 1;4(2):116-34. eCollection 2014.

Epidermal growth factor receptor (EGFR)-RAS signaling pathway in penile squamous cell carcinoma.

PLoS One. 2013 Apr 24;8(4):e62175. doi: 10.1371/journal.pone.0062175. Print 2013.

Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16.

Virology. 2011 Dec 5;421(1):19-27. doi: 10.1016/j.virol.2011.09.014. Epub 2011 Oct 5.

The Role of EGFR Inhibitors in the Treatment of Metastatic Anal Canal Carcinoma: A Case Series.

J Oncol. 2011;2011:125467. doi: 10.1155/2011/125467. Epub 2011 Jun 13.